<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

News and Stories

By Author

Erika Matich

Dental van provides care to low-income residents

CU SmileMaker provides more access to care Justin Smatz, a fourth-year dental school student, checks the teeth of a patient in the CU SmileMaker moblie dental clinic.

Author Erika Matich | Publish Date January 15, 2012
Full Story

Breast Cancer Finding

Within many hormone-receptor positive breast cancers lives a subpopulation of receptor-negative cells – knock down the hormone-receptor positive cells with anti-estrogen drugs and you may inadvertently promote tumor takeover by more dangerous, receptor-negative cells.

Author Erika Matich | Publish Date October 31, 2011
Full Story

Cancer survivor clinical trial

University of Colorado Cancer Center is looking for cancer survivors to take part in a clinical trial of a program aimed at helping them manage their condition more effectively. The program, called “Cancer: Thriving and Surviving,” is adapted from a successful effort helping people manage other chronic conditions like diabetes.

Author Erika Matich | Publish Date July 24, 2011
Full Story

Lung Cancer Screening

Results from the National Lung Screening Trial, published today in the New England Journal of Medicine, show that patients who receive low-dose computerized tomography (LDCT) scans once per year for three years to detect lung cancer experience a 20 percent lower risk of death from lung cancer than those who are screened using standard chest X-rays. This finding led National Cancer Institute (NCI) investigators to halt the study early and release results.

Author Erika Matich | Publish Date June 29, 2011
Full Story

Benefit of targeted lung cancer therapy confirmed


A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).

Author Erika Matich | Publish Date June 05, 2011
Full Story

Super-survivor population for established lung cancer treatment

A discovery at University of Colorado Cancer Center shows testing lung cancer on a molecular level can produce new insights into this deadly disease.

Author Erika Matich | Publish Date March 07, 2011
Full Story

Patients Have New Resource in Cancer Journey

The American Cancer Society today launched its Patient Navigator Program at the University of Colorado Cancer Center, thanks to support received from AstraZeneca. This is the 4th Patient Navigator Program site, and the 4th in Colorado as part of a strategic nationwide effort to significantly extend the reach of this innovative program and assist individual cancer patients in negotiating the health care system.

Author Erika Matich | Publish Date March 11, 2010
Full Story

New Alzheimer's treatments possible

New therapies for people with Alzheimer’s disease could be the result of an important study at the University of Colorado Denver School of Medicine. The study shows a brain protein that plays a key role in cognitive function and removal of toxins is inhibited in the brains of people with Alzheimer’s.

Author Erika Matich | Publish Date April 17, 2009
Full Story